ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 153 filers reported holding ENDOLOGIX INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $91,000 | +23.0% | 16,113 | -8.2% | 0.00% | – |
| Q1 2018 | $74,000 | -48.6% | 17,544 | -34.8% | 0.00% | -100.0% |
| Q4 2017 | $144,000 | +11.6% | 26,894 | +160.3% | 0.00% | 0.0% |
| Q2 2016 | $129,000 | +72.0% | 10,333 | +15.8% | 0.00% | 0.0% |
| Q1 2016 | $75,000 | +25.0% | 8,926 | +48.2% | 0.00% | – |
| Q4 2015 | $60,000 | -37.5% | 6,021 | -23.4% | 0.00% | -100.0% |
| Q3 2015 | $96,000 | +152.6% | 7,857 | +216.7% | 0.00% | – |
| Q2 2015 | $38,000 | +8.6% | 2,481 | +22.2% | 0.00% | – |
| Q1 2015 | $35,000 | +12.9% | 2,030 | +0.1% | 0.00% | – |
| Q4 2014 | $31,000 | +24.0% | 2,028 | -13.7% | 0.00% | – |
| Q3 2014 | $25,000 | -28.6% | 2,351 | +2.0% | 0.00% | – |
| Q2 2014 | $35,000 | -7.9% | 2,305 | -21.4% | 0.00% | – |
| Q1 2014 | $38,000 | -2.6% | 2,934 | +31.0% | 0.00% | – |
| Q4 2013 | $39,000 | -68.0% | 2,239 | -70.3% | 0.00% | -100.0% |
| Q3 2013 | $122,000 | +130.2% | 7,536 | +88.0% | 0.00% | – |
| Q2 2013 | $53,000 | – | 4,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,121,447 | $5,450,000 | 2.37% |
| Essex Woodlands Management, Inc. | 1,257,468 | $11,699,000 | 2.12% |
| Redmile Group, LLC | 6,368,299 | $30,950,000 | 1.88% |
| Camber Capital Management LP | 7,500,000 | $36,450,000 | 1.78% |
| Sio Capital Management, LLC | 493,060 | $2,396,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 1,575,000 | $7,655,000 | 1.10% |
| PFM Health Sciences, LP | 5,599,466 | $27,213,000 | 0.73% |
| Elk Creek Partners, LLC | 2,087,238 | $10,144,000 | 0.66% |
| Partner Investment Management, L.P. | 99,736 | $485,000 | 0.65% |
| Brown Capital Management | 8,783,162 | $42,686,000 | 0.52% |